Zomedica Future Growth
Future criteria checks 2/6
Zomedica is forecast to grow earnings and revenue by 23.3% and 25.2% per annum respectively while EPS is expected to grow by 23.7% per annum.
Key information
23.3%
Earnings growth rate
23.7%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 25.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 45 | -27 | N/A | N/A | 1 |
| 12/31/2025 | 35 | -30 | N/A | -26 | 1 |
| 12/31/2024 | 27 | -47 | N/A | -25 | 1 |
| 9/30/2024 | 27 | -62 | -31 | -24 | N/A |
| 6/30/2024 | 26 | -56 | -35 | -22 | N/A |
| 3/31/2024 | 26 | -37 | -32 | -19 | N/A |
| 12/31/2023 | 25 | -35 | -31 | -16 | N/A |
| 9/30/2023 | 24 | -15 | -28 | -13 | N/A |
| 6/30/2023 | 22 | -19 | -22 | -13 | N/A |
| 3/31/2023 | 21 | -19 | -21 | -13 | N/A |
| 12/31/2022 | 19 | -17 | -14 | -12 | N/A |
| 9/30/2022 | 17 | -17 | -16 | -14 | N/A |
| 6/30/2022 | 12 | -19 | -17 | -16 | N/A |
| 3/31/2022 | 8 | -18 | -15 | -14 | N/A |
| 12/31/2021 | 4 | -50 | -15 | -14 | N/A |
| 9/30/2021 | 0 | -51 | -12 | -12 | N/A |
| 6/30/2021 | 0 | -50 | -13 | -13 | N/A |
| 3/31/2021 | 0 | -51 | -17 | -17 | N/A |
| 12/31/2020 | N/A | -17 | -16 | -16 | N/A |
| 9/30/2020 | N/A | -16 | -15 | -15 | N/A |
| 6/30/2020 | N/A | -13 | -13 | -13 | N/A |
| 3/31/2020 | N/A | -11 | -16 | -15 | N/A |
| 12/31/2019 | N/A | -20 | -16 | -16 | N/A |
| 9/30/2019 | N/A | -25 | -18 | -17 | N/A |
| 6/30/2019 | N/A | -24 | -18 | -18 | N/A |
| 3/31/2019 | N/A | -26 | -13 | -12 | N/A |
| 12/31/2018 | N/A | -17 | -12 | -11 | N/A |
| 9/30/2018 | N/A | -11 | -10 | -10 | N/A |
| 6/30/2018 | N/A | -11 | N/A | -8 | N/A |
| 3/31/2018 | N/A | -8 | N/A | -7 | N/A |
| 12/31/2017 | N/A | -8 | N/A | -7 | N/A |
| 9/30/2017 | N/A | -8 | N/A | -7 | N/A |
| 6/30/2017 | N/A | -7 | N/A | -7 | N/A |
| 3/31/2017 | N/A | -7 | N/A | -5 | N/A |
| 12/31/2016 | N/A | -6 | N/A | -5 | N/A |
| 9/30/2016 | N/A | -4 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZOM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ZOM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ZOM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ZOM's revenue (25.2% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: ZOM's revenue (25.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ZOM's Return on Equity is forecast to be high in 3 years time